JAK2 c.1630_1632del ;(p.D544del)

Variant ID: 9-5070041-AGAT-A

NM_004972.3(JAK2):c.1630_1632del;(p.D544del)

This variant was identified in 16 publications

View GRCh38 version.




Publications:


Genetic Background of Polycythemia Vera.

Genes
Regimbeau, Mathilde M; Mary, Romain R; Hermetet, François F; Girodon, François F
Publication Date: 2022-04-02

Variant appearance in text: JAK2: D544del
PubMed Link: 35456443
Variant Present in the following documents:
  • Main text
  • genes-13-00637.pdf
View BVdb publication page



Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing.

Life (Basel, Switzerland)
Easwar, Arti A; Siddon, Alexa J AJ
Publication Date: 2021-10-30

Variant appearance in text: JAK2: D544del
PubMed Link: 34833034
Variant Present in the following documents:
  • Main text
  • life-11-01158.pdf
View BVdb publication page



Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera.

International Journal Of Molecular Sciences
Stuckey, Ruth R; Gómez-Casares, María Teresa MT
Publication Date: 2021-05-10

Variant appearance in text: JAK2: D544del
PubMed Link: 34068690
Variant Present in the following documents:
  • Main text
  • ijms-22-05042.pdf
View BVdb publication page



A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms.

Cancers
Guijarro-Hernández, Ana A; Vizmanos, José Luis JL
Publication Date: 2021-02-26

Variant appearance in text: JAK2: D544del
PubMed Link: 33652860
Variant Present in the following documents:
  • Main text
  • cancers-13-00984.pdf
View BVdb publication page



JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.

Blood Advances
Pastore, Friederike F; Krishnan, Aishwarya A; Hammarén, Henrik M HM; Silvennoinen, Olli O; Yan, Benedict B; Levine, Ross L RL
Publication Date: 2020-09-22

Variant appearance in text: JAK2: D544del
PubMed Link: 32956452
Variant Present in the following documents:
  • Main text
View BVdb publication page



Diagnosis of exon 12-positive polycythemia vera rescued by NGS.

Clinical Case Reports
Geay, Antoine A; Aral, Bernard B; Bourgeois, Valentin V; Martin, Pauline P; Airaud, Fabrice F; Garrec, Céline C; Bézieau, Stéphane S; Gardie, Betty B; Girodon, François F
Publication Date: 2020-05

Variant appearance in text: JAK2: D544del
PubMed Link: 32477518
Variant Present in the following documents:
  • Main text
  • CCR3-8-790.pdf
View BVdb publication page



Recent insights regarding the molecular basis of myeloproliferative neoplasms.

The Korean Journal Of Internal Medicine
Jang, Mi-Ae MA; Choi, Chul Won CW
Publication Date: 2020-01

Variant appearance in text: JAK2: D544del
PubMed Link: 31778606
Variant Present in the following documents:
  • Main text
  • kjim-2019-317.pdf
View BVdb publication page



HIF2A germline-mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma.

Cancer Biology & Therapy
Liu, Qiuli Q; Tong, Dali D; Liu, Gaolei G; Yi, Yuting Y; Zhang, Dianzheng D; Zhang, Jun J; Zhang, Yao Y; Huang, Zaoming Z; Li, Yaoming Y; Chen, Rongrong R; Guan, Yanfang Y; Yi, Xin X; Jiang, Jun J
Publication Date: 2017-12-02

Variant appearance in text: JAK2: D544del
PubMed Link: 29172931
Variant Present in the following documents:
  • Main text
  • kcbt-18-12-1394553.pdf
View BVdb publication page



Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms.

Iranian Journal Of Public Health
Makani, Zahra Z; Mirzaahmadi, Sina S; Motallebi, Marzieh M; Movafagh, Abolfazl A
Publication Date: 2017-11

Variant appearance in text: JAK2: D544del
PubMed Link: 29167785
Variant Present in the following documents:
  • Main text
View BVdb publication page



Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview.

Revista Brasileira De Hematologia E Hemoterapia
de Freitas, Renata Mendes RM; da Costa Maranduba, Carlos Magno CM
Publication Date: 2015

Variant appearance in text: JAK2: D544del
PubMed Link: 26408371
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Comprehensive review of JAK inhibitors in myeloproliferative neoplasms.

Therapeutic Advances In Hematology
Sonbol, Mohamad Bassam MB; Firwana, Belal B; Zarzour, Ahmad A; Morad, Mohammad M; Rana, Vishal V; Tiu, Ramon V RV
Publication Date: 2013-02

Variant appearance in text: JAK2: D544del
PubMed Link: 23610611
Variant Present in the following documents:
  • Main text
View BVdb publication page



A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden.

Plos One
Kjær, Lasse L; Westman, Maj M; Hasselbalch Riley, Caroline C; Høgdall, Estrid E; Weis Bjerrum, Ole O; Hasselbalch, Hans H
Publication Date: 2012

Variant appearance in text: JAK2: D544del
PubMed Link: 22403733
Variant Present in the following documents:
  • Main text
View BVdb publication page



Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies.

Oncotarget
Passamonti, Francesco F; Maffioli, Margherita M; Caramazza, Domenica D; Cazzola, Mario M
Publication Date: 2011-06

Variant appearance in text: JAK2: D544del
PubMed Link: 21646683
Variant Present in the following documents:
  • Main text
  • oncotarget-02-485.pdf
View BVdb publication page



Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.

The Journal Of Molecular Diagnostics : Jmd
Laughlin, Todd S TS; Moliterno, Alison R AR; Stein, Brady L BL; Rothberg, Paul G PG
Publication Date: 2010-05

Variant appearance in text: JAK2: D544del
PubMed Link: 20203004
Variant Present in the following documents:
  • Main text
View BVdb publication page



Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.

Plos One
Ugo, Valerie V; Tondeur, Sylvie S; Menot, Marie-Laurence ML; Bonnin, Nadine N; Le Gac, Gerald G; Tonetti, Carole C; Mansat-De Mas, Veronique V; Lecucq, Lydie L; Kiladjian, Jean-Jacques JJ; Chomienne, Christine C; Dosquet, Christine C; Parquet, Nathalie N; Darnige, Luc L; Porneuf, Marc M; Escoffre-Barbe, Martine M; Giraudier, Stephane S; Delabesse, Eric E; Cassinat, Bruno B; ,
Publication Date: 2010-01-26

Variant appearance in text: JAK2: D544del
PubMed Link: 20126644
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Journal Of Cellular And Molecular Medicine
Tefferi, Ayalew A
Publication Date: 2009-02

Variant appearance in text: JAK2: D544del
PubMed Link: 19175693
Variant Present in the following documents:
  • Main text
  • jcmm0013-0215.pdf
View BVdb publication page